Today's Family Medicine News Highlights
September 1, 2014
The Globe and Mail
Aids cure possible but is it affordable?
The Toronto Star
Editorial – agreement on need for revamped senior health care strategy
Foreign medical grads find Ontario’s system a challenge
Comment: Needless controversy on marijuana
Toddler in Gatineau tested negative for ebola virus
Questions d’éthique soulevées par l’Ébola
Les personnes handicapées revendiquent plus d’aide du gouvernement
L’entretien des hôpitaux menacé par les coupures
Des médecins et experts québécois se prononcent sur les vapoteurs
Le Journal de Montréal
Détection précoce du cancer de la vessie par du sang invisible dans l’urine
The Medical Post
REGINA | The Saskatchewan government is to begin providing coverage for a cystic fibrosis drug starting next week.
The province says the oral medication Kalydeco will be covered starting Monday.
The drug can be expensive with costs running to $300,000 a year for one patient.
Drug-maker Vertex Pharmaceuticals reached an agreement with the provincial and territorial governments in June to enable public drug plans to cover the medication’s cost.
Negotiations had been going on for more than a year.
It’s believed to be the first drug that corrects the faulty mechanism that causes cystic fibrosis in the first place.
The drug only works for a small subset of patients whose disease is caused by a mutation on the specific gene.